Banka BioLoo Receives NSE Trading Approval for 5,000 ESOP Equity Shares
Banka BioLoo Ltd 路 Others (Uncategorized) 路 14 Nov 2026, 12:40 am
Banka BioLoo Receives NSE Trading Approval for 5,000 ESOP Equity Shares Banka BioLoo Limited received listing and trading approval from the National Stock Exchange of India (NSE) on 13th Nov'26 for 5,000 equity shares of face value Rs. 10 each issued under its Employee Stock Option Plan (ESOP). The shares (distinctive numbers 10931933 to 10936932) are admitted to dealings under the symbol BANKA with trading effective from 16th Nov'26.
Original exchange filing (PDF)
More announcements from Banka BioLoo Ltd
- Unaudited financial results for the quarter and half year ended 30 September 2026. 路 13 Nov 2026
- Banka BioLoo Limited has informed the Exchange regarding 'Financial results for the quarter and half year ended 30 September 2026'. 路 12 Nov 2026
- Banka BioLoo Limited has informed the Exchange about Investor Presentation 路 12 Nov 2026
- Banka BioLoo Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 12 Nov 2026
- Significant movement in price has been observed in Banka BioLoo Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Banka BioLoo Limited has submitted their response. 路 10 Nov 2026
- Significant movement in price has been observed in Banka BioLoo Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. 路 10 Nov 2026
- BANKA BIOLOO LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 12 Nov 2026
- To consider and approve the financial results and other inter alia business matters for the period ended September 30, 2026 路 12 Nov 2026
